Surgical Management of Hereditary Nonpolyposis Colorectal Cancer

Advances in Surgery

Volumn 45, Issue 1, 2011, Pages 265-274

  Kalady, Matthew F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLON RESECTION; COLON TUMOR; FEMALE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; LAPAROSCOPY; METHODOLOGY; MULTIPLE CANCER; PATHOLOGY; QUALITY OF LIFE; RECTUM TUMOR; REVIEW; UTERUS CANCER;

COLECTOMY; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; HUMANS; LAPAROSCOPY; NEOPLASMS, MULTIPLE PRIMARY; QUALITY OF LIFE; RECTAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 79961201212     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yasu.2011.03.009     Document Type: Review

References (46)

1. Hampel H., Frankel W.L., Martin E., et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 2008, 26(35):5783-5788.
2. Lynch H.T., Kimberling W., Albano W.A., et al. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer 1985, 56(4):934-938.
3. Lynch H.T., Schuelke G.S., Kimberling W.J., et al. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies. Cancer 1985, 56(4):939-951.
4. Vasen H.F., Mecklin J.P., Khan P.M., et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991, 34(5):424-425.
5. Vasen H.F., Watson P., Mecklin J.P., et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999, 116(6):1453-1456.
6. Kalady M.F., McGannon E., Vogel J.D., et al. Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria. Ann Surg 2010, 252(3):507-511.
7. Leach F.S., Nicolaides N.C., Papadopoulos N., et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993, 75(6):1215-1225.
8. Fishel R., Lescoe M.K., Rao M.R., et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1994, 77(1):1-166. [erratum for Cell 1993 Dec 3;75(5):1027-38; PMID: 8252616].
9. Bronner C.E., Baker S.M., Morrison P.T., et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994, 368(6468):258-261.
10. Lynch H.T., de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003, 348(10):919-932.
11. Jass J.R. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 2006, 12(31):4943-4950.
12. Lindor N.M., Rabe K., Petersen G.M., et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005, 293(16):1979-1985.
13. Vasen H.F., Wijnen J.T., Menko F.H., et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterol 1996, 110(4):1020-1027.
14. Aarnio M., Sankila R., Pukkala E., et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999, 81(2):214-218.
15. de Vos tot Nederveen Cappel W.H., Nagengast F.M., Griffioen G., et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum 2002, 45(12):1588-1594.
16. Fitzgibbons R.J., Lynch H.T., Stanislav G.V., et al. Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). Ann Surg 1987, 206(3):289-295.
17. Stoffel E., Mukherjee B., Raymond V.M., et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterol 2009, 137(5):1621-1627.
18. Jasperson K.W., Tuohy T.M., et al. Hereditary and familial colon cancer. Gastroenterol 2010, 138(6):2044-2058.
19. Vasen H.F., Abdirahman M., Brohet R., et al. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterol 2010, 138(7):2300-2306.
20. Jarvinen H.J., Aarnio M., Mustonen H., et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterol 2000, 118(5):829-834.
21. Jarvinen H.J., Mecklin J.P., Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterol 1995, 108(5):1405-1411.
22. Burt R.W., Barthel J.S., Dunn K.B., et al. NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw 2010, 8(1):8-61.
23. Church J., Simmang C. Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). Dis Colon Rectum 2003, 46(8):1001-1012.
24. Syngal S., Weeks J.C., Schrag D., et al. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 1998, 129(10):787-796.
25. Guillem J.G., Wood W.C., Moley J.F., et al. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Ann Surg Oncol 2006, 13(10):1296-1321.
26. de Vos tot Nederveen Cappel W.H., Buskens E., van Duijvendijk P., et al. Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut 2003, 52(12):1752-1755.
27. Vasen H.F., Mecklin J.P., Watson P., et al. Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. The International Collaborative Group on HNPCC. Dis Colon Rectum 1993, 36(1):1-4.
28. Rodriguez-Bigas M.A., Vasen H.F., Pekka-Mecklin J., et al. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg 1997, 225(2):202-207.
29. Van Dalen R., Church J., McGannon E., et al. Patterns of surgery in patients belonging to Amsterdam-positive families. Dis Colon Rectum 2003, 46(5):617-620.
30. Natarajan N., Watson P., Silva-Lopez E., et al. Comparison of extended colectomy and limited resection in patients with Lynch syndrome. Dis Colon Rectum 2010, 53(1):77-82.
31. Rijcken F.E., Hollema H., Kleibeuker J.H., et al. Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut 2002, 50(3):382-386.
32. Lindgren G., Liljegren A., Jaramillo E., et al. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut 2002, 50(2):228-234.
33. Rijcken F.E., Koornstra J.J., van der Sluis T., et al. Early carcinogenic events in HNPCC adenomas: differences with sporadic adenomas. Dig Dis Sci 2008, 53(6):1660-1668.
34. Stoffel E.M., Turgeon D.K., Stockwell D.H., et al. Missed adenomas during colonoscopic surveillance in individuals with Lynch syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila) 2008, 1(6):470-475.
35. Lynch A.C., Church J.M., Lavery I.C. Quality of life following partial or total colectomy: relevance to hereditary non-polyposis colorectal cancer. Dis Colon Rectum 2003, 46:55.
36. Beckwith P.S., Wolff B.G., Frazee R.C. Ileorectostomy in the older patient. Dis Colon Rectum 1992, 35(4):301-304.
37. Church J.M., Fazio V.W., Lavery I.C., et al. Quality of life after prophylactic colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum 1996, 39(12):1404-1408.
38. Fleshman J., Sargent D.J., Green E., et al. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg 2007, 246(4):655-662. [discussion: 662-4].
39. Nelson H., Sargent D.J., Wieand H. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004, 350(20):2050-2059.
40. Lacy A.M., Garcia-Valdecasas J.C., Delgado S., et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 2002, 359(9325):2224-2229.
41. Lee J.S., Petrelli N.J., Rodriguez-Bigas M.A. Rectal cancer in hereditary nonpolyposis colorectal cancer. Am J Surg 2001, 181(3):207-210.
42. Moslein G., Nelson H., Thibodeau S., et al. Rectal carcinomas in HNPCC. Langenbecks Arch Chir Suppl Kongressbd 1998, 115:1467-1469. [in German].
43. Dove-Edwin I., Boks D., Goff S., et al. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 2002, 94(6):1708-1712.
44. Lindor N.M., Petersen G.M., Hadley D.W., et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006, 296(12):1507-1517.
45. Schmeler K.M., Lynch H.T., Chen L.M., et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006, 354(3):261-269.
46. Vasen H.F., Moslein G., Alonso A., et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007, 44(6):353-362.